Financhill
Sell
16

NMTC Quote, Financials, Valuation and Earnings

Last price:
$0.60
Seasonality move :
-18.81%
Day range:
$0.50 - $0.60
52-week range:
$0.40 - $1.39
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.80x
P/B ratio:
5.94x
Volume:
502.3K
Avg. volume:
309.5K
1-year change:
-50.9%
Market cap:
$17.4M
Revenue:
$3.5M
EPS (TTM):
-$0.26

Earnings Data

Next earnings date for NMTC
May 14
2025
Most recent earnings per share
$0.06
Beat by $0.06
(Feb 12/2025)
Consensus Estimate
--
(Feb 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

NMTC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/12/2025 Q4 -- $3.3M $0.06 -- --
12/17/2024 Q3 -- $272.3K -$0.11 -- --
08/14/2024 Q2 -- $825.8K -$0.10 -- --
05/14/2024 Q1 -- $1.4M -$0.11 -- --
02/13/2024 Q4 $852K $977.7K -$0.14 -$0.14 --
12/14/2023 Q3 -- -- -$0.13 -$0.18 $0.05
08/11/2023 Q2 -- -- -$0.20 -$0.21 $0.00
05/12/2023 Q1 -- -- -$0.21 -$0.21 -$0.01
02/14/2023 Q4 -- -- -$0.11 -$0.11 --
12/13/2022 Q3 -- -- -$0.09 -$0.11 $0.02
08/11/2022 Q2 -- -- -$0.17 -$0.23 $0.06
05/12/2022 Q1 -- -- -$0.19 -$0.20 $0.01
02/14/2022 Q4 -- -- -$0.18 -$0.19 $0.01
12/15/2021 Q3 -- -- -$0.22 -$0.24 $0.02
08/13/2021 Q2 -- -- -$0.25 -- --
05/14/2021 Q1 -- -- -$0.21 -- --
12/31/2020 Q4 -- -- -$0.27 -- --
09/30/2020 Q3 -- -- $0.18 -- --
06/30/2020 Q2 -- -- -$1.32 -- --
03/31/2020 Q1 -- -- -$0.87 -- --
12/31/2019 Q4 -- -- -$1.02 -- --
09/30/2019 Q3 -- -- -$0.27 -- --
06/30/2019 Q2 -- -- -$0.42 -- --
03/31/2019 Q1 -- -- -$0.60 -- --
12/31/2018 Q4 -- -- -$0.42 -- --
06/30/2018 Q2 -- -- -$0.48 -- --
03/31/2018 Q1 -- -- -$0.51 -- --
12/31/2017 Q4 -- -- -$0.66 -- --
09/30/2017 Q3 -- -- -$0.57 -- --
06/30/2017 Q2 -- -- -$0.66 -- --
03/31/2017 Q1 -- -- -$0.42 -- --
12/31/2016 Q4 -- -- -$0.18 -- --
09/30/2016 Q3 -- -- -$0.00 -- --
06/30/2016 Q2 -- -- -$0.01 -- --
03/31/2016 Q1 -- -- -$0.01 -- --
12/31/2015 Q4 -- -- -- -- --
09/30/2015 Q3 -- -- -$0.01 -- --
06/30/2015 Q2 -- -- -$0.01 -- --

NeuroOne Medical Technologies Earnings Questions

  • How Much did NeuroOne Medical Technologies Generate in Revenue Last Quarter?

    NeuroOne Medical Technologies reported $3.3M worth of top line sales in its most recent quarter.

  • Did NeuroOne Medical Technologies Beat Earnings Last Quarter?

    NeuroOne Medical Technologies announced earnings per share of $0.06 which represents a beat of analyst forecast a -- per share.

  • Is NeuroOne Medical Technologies Profitable?

    NeuroOne Medical Technologies reported $1.9M that represents $0.06 per share over the last quarter.

  • What is the Analyst Consensus for NeuroOne Medical Technologies EPS Next Year?

    NeuroOne Medical Technologies's earnings are forecast to decrease from -$0.46 per share to -$0.70 per share next year representing a decrease of -36.92%.

  • When is NeuroOne Medical Technologies's Earnings Date?

    NeuroOne Medical Technologies's next earnings date is May 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Micron a Good Stock to Buy Now?
Is Micron a Good Stock to Buy Now?

Like most of its peers in the semiconductor industry, Micron…

Is Uber Finally on the Path to Consistent Profitability?
Is Uber Finally on the Path to Consistent Profitability?

After posting massive losses quarter after quarter for years, Uber…

How High Will MSTY Go By 2030?
How High Will MSTY Go By 2030?

YieldMax’s MSTR Option Income Strategy ETF (MSTY) is a high-yield…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 31x

Sell
42
Is NVDA Stock a Buy?

Market Cap: $2.5T
P/E Ratio: 36x

Alerts

Buy
91
TORXF alert for Apr 17

Torex Gold Resources [TORXF] is down 2.18% over the past day.

Sell
25
BULZ alert for Apr 17

MicroSectors Solactive FANG & Innov 3X Levd ETN [BULZ] is down 0% over the past day.

Sell
44
VIST alert for Apr 17

Vista Energy SAB de CV [VIST] is up 7.24% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock